2021
DOI: 10.1016/j.jtct.2020.11.016
|View full text |Cite
|
Sign up to set email alerts
|

Sinusoidal Obstruction Syndrome in Critically Ill Patients in the Era of Defibrotide: A Retrospective Multicenter Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 30 publications
0
2
0
1
Order By: Relevance
“…Many penicillins, carbapenems, and cephalosporins are metabolized and/or excreted through the kidneys. 10 , 29 Lower doses and/or modified dosing intervals are often necessary until the patient’s renal function returns to baseline.…”
Section: Composition and Practices Of A Collaborative Vod/sos Teammentioning
confidence: 99%
See 1 more Smart Citation
“…Many penicillins, carbapenems, and cephalosporins are metabolized and/or excreted through the kidneys. 10 , 29 Lower doses and/or modified dosing intervals are often necessary until the patient’s renal function returns to baseline.…”
Section: Composition and Practices Of A Collaborative Vod/sos Teammentioning
confidence: 99%
“…In some cases, pharmacists recommend not administering certain medications, such as aminoglycosides, whereas recommending dose modifications for others. Many penicillins, carbapenems, and cephalosporins are metabolized and/or excreted through the kidneys 10,29. Lower doses and/or modified dosing intervals are often necessary until the patient’s renal function returns to baseline.…”
Section: Composition and Practices Of A Collaborative Vod/sos Teammentioning
confidence: 99%
“…Частота встречаемости ВОБ/ССО среди госпитализированных в ОРИТ реципиентов алло-ГСК составила 5 % [27]. По данным многоцентрового исследования [73], посвященного оценке результатов лечения больных ВОБ/ССО в ОРИТ с применением дефибротида, был включен 71 больной с ВОБ/ССО (75 % -после алло-ТГСК, 11 % -после ауто-ТГСК, 14 %после химиотерапии, включая инотузумаб озогамицин и гемтузумаб озогамицин). Частота ВОБ/ССО крайне тяжелого течения составила 69 %, ОДН -68 %, ОПП -24 %, печеночной недостаточности -11 %, печеночной комы -8 %, ИВЛ проводили у 58 % больных, вазопрессорную терапию -у 52 %, заместительную почечную терапию (ЗПТ) -у 49 %.…”
Section: воб печениunclassified